ACADIA PHARMACEUTICALS INC — Director's Dealing 2015

Nov 30, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ACADIA PHARMACEUTICALS INC (ACAD)
CIK: 0001070494
Period of Report: 2015-11-25

Reporting Person: HARRIGAN EDMUND (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-11-25	Stock Option (right to buy)	$38.28	A	15000	Acquired	2025-11-24	Common Stock (15000)	Direct

Footnotes

F1: 50% of the shares subject to the Stock Option vest and become exercisable on each of the first and second anniversary of the date of grant.